Canada approves Pfizer/BioNTech COVID-19 vaccine, first shots expected next week

By Steve Scherer and Allison Martell OTTAWA/TORONTO (Reuters) - Canada on Wednesday approved its first COVID-19 vaccine, clearing the way for doses of the Pfizer Inc shots to be delivered and administered across the country as soon as next week. Canada is the third country after Britain and Bahrain to give the green light to the Pfizer vaccine, developed with Germany's BioNTech SE. 'The approval of the vaccine is supported by evidence that it is safe, effective and of good quality,' regulator Health Canada said in a statement.

Reuters December 10, 2020 01:11:07 IST
Canada approves Pfizer/BioNTech COVID-19 vaccine, first shots expected next week

COVID-19 vaccine, first shots expected next week" src="https://images.firstpost.com/wp-content/uploads/reuters/12-2020/10/2020-12-09T163020Z_1_LYNXMPEGB81BJ_RTROPTP_2_HEALTH-CORONAVIRUS-EUROPE-VACCINES.jpg" alt="Canada approves PfizerBioNTech COVID19 vaccine first shots expected next week" width="300" height="225" />

By Steve Scherer and Allison Martell

OTTAWA/TORONTO (Reuters) - Canada on Wednesday approved its first COVID-19 vaccine, clearing the way for doses of the Pfizer Inc shots to be delivered and administered across the country as soon as next week.

Canada is the third country after Britain and Bahrain to give the green light to the Pfizer vaccine, developed with Germany's BioNTech SE.

"The approval of the vaccine is supported by evidence that it is safe, effective and of good quality," regulator Health Canada said in a statement. It has initially been authorized for use in people 16 years of age or older.

The vaccine was approved under an interim, accelerated drug review system very similar to the U.S. Food and Drug Administration's emergency use authorizations, and comes a day before a panel of advisers to the FDA is set to review and recommend whether the U.S. agency should authorize use of the Pfizer vaccine.

On Tuesday, British citizens became the first in the world to get the shots outside of clinical trials following last week's UK approval.

In a large, late-stage trial, the vaccine was shown to be 95% effective at preventing illness, far better than originally anticipated.

However on Wednesday, Britain's medicine regulator advised that people with a history of significant allergies not get Pfizer's vaccine after two people reported adverse reactions on the first day of its rollout.

Responding to questions on the allergic reactions, Health Canada officials said that is always a risk with vaccines, but they are recommending that people who have previously had adverse reactions to any of the ingredients in the vaccine not to take it for now.

Officials said they would monitor developments in Britain to see if there were further implications for Canada.

Canada will receive an early shipment of up to 249,000 doses of Pfizer's vaccine by the end of the month, Prime Minister Justin Trudeau said on Monday.

Canada released a detailed plan for its vaccination rollout on Wednesday, saying that the nation is now "well-positioned to immunize 100% of the population in 2021." General inoculations for all Canadians would begin in April after priority populations have been vaccinated, it said.

The province of Saskatchewan said on Wednesday it expected to receive enough doses for 1,950 people by Tuesday intended first for healthcare workers in direct contact with COVID-19 patients.

Quebec expects to have received 55,000 doses of the vaccine by Jan. 4, the premier of the predominantly French-speaking province, Francois Legault, said.

'HISTORIC MOMENT'

"Today's decision from Health Canada is a historic moment in our collective fight against the COVID-19 pandemic and is a major step towards returning to normalcy in Canada," Cole Pinnow, president of Pfizer Canada, said in a statement.

Canada is in the midst of a virulent second wave of the pandemic, with Quebec's Legault saying he is weighing new restrictions and stepping up enforcement of current ones.

As of Tuesday, Canada had reported 429,035 total cases, an increase of 5,981 on the day before, and 12,867 deaths.

"We still need to reduce the pressure on our hospitals," Legault said.

Pfizer will be responsible for shipping its vaccine, which requires ultra-cold storage, to warehouses across Canada.

Canada has a firm order for 20 million doses of the vaccine, enough to inoculate 10 million people, with options to buy up to 56 million more.

For the most part, provincial and territorial health systems will administer the shots, for free. They will have final say over how to use scarce early supplies in their jurisdictions.

According to guidance published by the federal government, vulnerable people and those who look after them are high priority, including long-term care residents and some healthcare workers.

Regulators have received rolling applications for three other experimental vaccines, from Moderna Inc, AstraZeneca Plc and Johnson & Johnson.

The Moderna vaccine is farthest along, having completed pivotal trials showing it to be 94.1% effective at preventing illness and 100% at preventing severe COVID-19 .

Officials have said they expect to receive six million doses of Pfizer and Moderna vaccines before the end of March. Each vaccine requires two doses given about three weeks apart.

FedEx Corp and Innomar Strategies, a Canada-based unit of U.S. drug distributor AmerisourceBergen Corp, have been hired to provide logistical support on vaccine delivery.

(Reporting by Allison Martell in Toronto and Steve Scherer in Ottawa; additional reporting by David Ljunggren in Ottawa and Rod Nickel in Winnipeg and Allison Lampert in Montreal; editing by Bill Berkrot)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. wants faster vaccinations as pandemic worsens, job market suffers
World

U.S. wants faster vaccinations as pandemic worsens, job market suffers

By Maria Caspani and Dan Whitcomb (Reuters) -Federal, state and local officials sought to speed up slow-moving vaccinations on Thursday, a day after a record 4,000 Americans died and as employment statistics showed the pandemic and accompanying government lockdowns had slammed the job market. As of Thursday roughly 6 million people across the United States had been given the first of two shots, despite the nationwide distribution of more than 21 million doses, according to the U.S. Centers for Disease Control and Prevention.

U.S. transport chief, foreign policy aides quit after Capitol violence
World

U.S. transport chief, foreign policy aides quit after Capitol violence

By David Shepardson, Matt Spetalnick and Steve Holland WASHINGTON (Reuters) -U.S. Transportation Secretary Elaine Chao announced her resignation on Thursday, the first Cabinet member to join a list of officials of President Donald Trump's administration who are leaving in protest at the storming of the U.S. Capitol by his supporters

Premature to talk about compensation for Iran's 2020 downing of airliner, says Canadian aide
World

Premature to talk about compensation for Iran's 2020 downing of airliner, says Canadian aide

OTTAWA (Reuters) - It is too early to discuss how much compensation to pay relatives of those killed when Iran shot down an airliner last year, even though Tehran has suggested an amount, a Canadian adviser said on Thursday. Many of the victims were Canadian citizens or permanent residents of Canada. Last month Iran's cabinet allocated $150,000 for each family of the 176 people who died when Revolutionary Guards downed the Ukraine International Airlines plane near Tehran on Jan